Stay updated on LN-144 Clinical Trial in Metastatic Melanoma
Sign up to get notified when there's something new on the LN-144 Clinical Trial in Metastatic Melanoma page.

Latest updates to the LN-144 Clinical Trial in Metastatic Melanoma page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedSite location was updated from Napoli, Italy, 80131 to Naples, Italy, 80131. The Study Plan adds a 'Maximum 60 months' time frame for outcomes and expands the Safety Profile to specify incidence, seriousness, relationship to treatment, and characteristics of treatment-emergent adverse events.SummaryDifference0.3%

- Check19 days agoChange DetectedRevision: v3.5.0 has been added and v3.4.3 has been removed. This update appears to be a platform version change rather than a modification to study content or user-facing information.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No visible changes to study details or page content.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded Revision: v3.4.2, and removed the government funding lapse notice and Revision: v3.4.1 entry.SummaryDifference0.3%

- Check61 days agoChange DetectedA site-wide notice about government funding status and operating status was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check68 days agoChange DetectedThe page now shows a glossary toggle and adds explicit data fields for Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. It also removes the estimated versions of Results First Posted and Last Update Posted, and updates the No FEAR Act data label and the revision history from v3.3.4 to v3.4.0.SummaryDifference0.2%

Stay in the know with updates to LN-144 Clinical Trial in Metastatic Melanoma
Enter your email address, and we'll notify you when there's something new on the LN-144 Clinical Trial in Metastatic Melanoma page.